Dr. Raj Patil is Sr. Director of Research & Development at OKYO Pharma. Dr. Patil brings more than 25 years of academic and pharmaceutical experience in Ophthalmology and inflammatory diseases. OKYO Pharma Limited (LSE: OKYO) is a biopharmaceutical company developing next-generation therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. Our goal is to develop first in class drug candidates that prevent the disease instead of controlling it, and we achieve this through our collaboration with pioneer scientists in the field.
Share Talk
Designed for Private - Retail Investors, bloggers, brokers, PR, listed companies to communicate on one information portal. Please note we are an unregulated website and will never give out advice. We are here to make investing a level playing field.
